A noninvasive renal fungus ball caused by Rhizopus a previously unreported manifestation of zygomycosis

Medical Mycology

Volumn 48, Issue 6, 2010, Pages 866-869

  Palacio Bedoya, Federico ^a,b,c   Cadena, Jose A ^b,c   Thompson III, George R ^b,c   Sutton, Deanna A ^a   Owens, Aaron D ^a,b   Patterson, Thomas F ^b,c  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

Fungus ball; Mucormycosis; Renal; Rhizopus; Zygomycetes

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; FLUCONAZOLE; POSACONAZOLE;

ADULT; ARTICLE; BEZOAR; CASE REPORT; DRUG INSTILLATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FLANK PAIN; HEMATURIA; HUMAN; HUMAN TISSUE; INTRAVENOUS PYELOGRAPHY; KIDNEY FAILURE; KIDNEY PELVIS; MALE; MUCORMYCOSIS; OLIGURIA; PERCUTANEOUS NEPHROSTOMY; RECURRENT INFECTION; RHIZOPUS ORYZAE; SALVAGE THERAPY; SURGICAL DRAINAGE; URETER; WEIGHT REDUCTION;

ADULT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; HUMANS; KIDNEY DISEASES; KIDNEY PELVIS; MALE; MUCORMYCOSIS; RENAL INSUFFICIENCY; RHIZOPUS; TRIAZOLES; URETER;

FUNGI; RHIZOPUS; ZYGOMYCETES;

EID: 77955879918     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693781003694796     Document Type: Article

References (20)

1. Kontoyiannis DP, Lionakis MS, Lewis RE, et al. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus -active antifungal therapy: a case-control observational study of 27 recent cases. J Inf Dis 2005; 191: 1350-1360.
2. Chayakulkeeree M, Ghannoum MA, Perfect JR. Zygomycosis: the re-emerging fungal infection. Eur J Clin Microbiol Infect Dis 2006; 25: 215-229.
3. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005; 41: 634-653.
4. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin MicrobiolRev 2000; 13: 236-301.
5. Lussier N, Laverdiere M, Weiss K, Poirier L, Schick E. Primary renal mucormycosis. Urology 1998; 52: 900-903.
6. Weng DE, Wilson WH, Little R, Walsh TJ. Successful medical management of isolated renal zygomycosis: case report and review. Clin Infect Dis 1998; 26: 601-605.
7. Sampol BJ. Obstructive fungus ball in kidney allografts. Actas Urol Esp 2008; 32: 267.
8. Wimalendra M, Reece A, Nicholl RM. Renal fungal ball. A rch Dis Child Fetal Neonatal Ed 2004; 89: F376.
9. Roehrl MH, Croft WJ, Liao Q, Wang JY, Kradin RL. Hemorrhagic pulmonary oxalosis secondary to a noninvasive Aspergillus niger fungus ball. Virchows Arch 2007; 451: 1067-1073.
10. Wingard JR CS, Walsh TJ, Kurtzberg J, et al. Results of fluconazole (FLU) vs voriconazole (VORI) for the prevention of invasive fungal infections (IFI) in 600 allogeneic blood and marrow transplant (BMT) patients. Blood 2007; 110: 55a. Abstract #163.
11. Arikan S, Sancak B, Alp S, Hascelik G, McNicholas P. Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus. Med Mycol 2008; 46: 567-573.
12. Notheis G, Tarani L, Costantino F, et al. Posaconazole for treatment of refractory invasive fungal disease. Mycoses 2006; 49 (Suppl. 1): 37-41.
13. Yu J, Li RY. Primary renal zygomycosis due to R hizopus oryzae. M ed Mycol 2006; 44: 461-466.
14. Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 503-535.
15. Irby PB, Stoller ML, McAninch JW. Fungal bezoars of the upper urinary tract. J Urol 1990; 143: 447-451.
16. Ortiz O, Lee WJ. Percutaneous nephrostomy in the management of renal candidiasis. Arch Surg 1989; 124: 739-740.
17. Govitrapong P, Suttitum T, Kotchabhakdi N, Uneklabh T. Alterations of immune functions in heroin addicts and heroin withdrawal subjects. J Pharmacol Exp Ther 1998; 286: 883-889.
18. Greenberg RN, Mullane K, van Burik JA, et al. Posaconazole as salvage therapy for zygomycosis. Antimicrob AgentsChemother 2006; 50: 126-133.
19. van Burik JA, Hare RS, Solomon HF, Corrado ML, Kontoyiannis DP. Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin Infect Dis 2006; 42: e61-65.
20. Posaconazole [package insert]. Kenilworth NSC.